chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood chloride increased, Blood creatinine, Blood glucose normal, Blood potassium normal, Blood sodium normal
Clinical narrative: dysphagia, dyspnea, edema Narrative: Pt c/o neck swelling/angioedema, dysphagia, dyspnea, and edema on 3/8/21 three hours after COVID-19 (Pfizer) vaccine administration. Pt was admitted to hospital and discharged on 3/11/21. Pt with recurring sx's hours after discharge and readmitted to hospital on 3/11/21. Pt was transferred to ICU on the same day and discharged on 3/14/21. Pt with another episode of recurring sxs on 3/15/21 and referred by provider on 3/16/21 to go to ED. Pt was seen in ED and discharged with low-dose steroid taper. Told that vaccine needed to get out of system and that after vaccine had run its course that sxs would improve.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urea normal, Carbon dioxide normal, Dysphagia, Dyspnoea, Eosinophil count normal
Clinical narrative: dysphagia, dyspnea, edema Narrative: Pt c/o neck swelling/angioedema, dysphagia, dyspnea, and edema on 3/8/21 three hours after COVID-19 (Pfizer) vaccine administration. Pt was admitted to hospital and discharged on 3/11/21. Pt with recurring sx's hours after discharge and readmitted to hospital on 3/11/21. Pt was transferred to ICU on the same day and discharged on 3/14/21. Pt with another episode of recurring sxs on 3/15/21 and referred by provider on 3/16/21 to go to ED. Pt was seen in ED and discharged with low-dose steroid taper. Told that vaccine needed to get out of system and that after vaccine had run its course that sxs would improve.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Eosinophil percentage increased, Glomerular filtration rate normal, Haematocrit increased, Haemoglobin increased, Immature granulocyte count increased
Clinical narrative: dysphagia, dyspnea, edema Narrative: Pt c/o neck swelling/angioedema, dysphagia, dyspnea, and edema on 3/8/21 three hours after COVID-19 (Pfizer) vaccine administration. Pt was admitted to hospital and discharged on 3/11/21. Pt with recurring sx's hours after discharge and readmitted to hospital on 3/11/21. Pt was transferred to ICU on the same day and discharged on 3/14/21. Pt with another episode of recurring sxs on 3/15/21 and referred by provider on 3/16/21 to go to ED. Pt was seen in ED and discharged with low-dose steroid taper. Told that vaccine needed to get out of system and that after vaccine had run its course that sxs would improve.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, Lymphocyte count normal, Lymphocyte percentage decreased, Mean cell haemoglobin concentration decreased, Mean cell haemoglobin increased
Clinical narrative: dysphagia, dyspnea, edema Narrative: Pt c/o neck swelling/angioedema, dysphagia, dyspnea, and edema on 3/8/21 three hours after COVID-19 (Pfizer) vaccine administration. Pt was admitted to hospital and discharged on 3/11/21. Pt with recurring sx's hours after discharge and readmitted to hospital on 3/11/21. Pt was transferred to ICU on the same day and discharged on 3/14/21. Pt with another episode of recurring sxs on 3/15/21 and referred by provider on 3/16/21 to go to ED. Pt was seen in ED and discharged with low-dose steroid taper. Told that vaccine needed to get out of system and that after vaccine had run its course that sxs would improve.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Mean cell volume increased, Mean platelet volume normal, Monocyte count normal, Monocyte percentage increased, Neutrophil count normal
Clinical narrative: dysphagia, dyspnea, edema Narrative: Pt c/o neck swelling/angioedema, dysphagia, dyspnea, and edema on 3/8/21 three hours after COVID-19 (Pfizer) vaccine administration. Pt was admitted to hospital and discharged on 3/11/21. Pt with recurring sx's hours after discharge and readmitted to hospital on 3/11/21. Pt was transferred to ICU on the same day and discharged on 3/14/21. Pt with another episode of recurring sxs on 3/15/21 and referred by provider on 3/16/21 to go to ED. Pt was seen in ED and discharged with low-dose steroid taper. Told that vaccine needed to get out of system and that after vaccine had run its course that sxs would improve.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Neutrophil percentage increased, Oedema, Plasma cell count, Platelet count normal, Protein total normal
Clinical narrative: dysphagia, dyspnea, edema Narrative: Pt c/o neck swelling/angioedema, dysphagia, dyspnea, and edema on 3/8/21 three hours after COVID-19 (Pfizer) vaccine administration. Pt was admitted to hospital and discharged on 3/11/21. Pt with recurring sx's hours after discharge and readmitted to hospital on 3/11/21. Pt was transferred to ICU on the same day and discharged on 3/14/21. Pt with another episode of recurring sxs on 3/15/21 and referred by provider on 3/16/21 to go to ED. Pt was seen in ED and discharged with low-dose steroid taper. Told that vaccine needed to get out of system and that after vaccine had run its course that sxs would improve.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell count increased, Red cell distribution width normal, Swelling, Symptom recurrence, White blood cell count decreased
Clinical narrative: dysphagia, dyspnea, edema Narrative: Pt c/o neck swelling/angioedema, dysphagia, dyspnea, and edema on 3/8/21 three hours after COVID-19 (Pfizer) vaccine administration. Pt was admitted to hospital and discharged on 3/11/21. Pt with recurring sx's hours after discharge and readmitted to hospital on 3/11/21. Pt was transferred to ICU on the same day and discharged on 3/14/21. Pt with another episode of recurring sxs on 3/15/21 and referred by provider on 3/16/21 to go to ED. Pt was seen in ED and discharged with low-dose steroid taper. Told that vaccine needed to get out of system and that after vaccine had run its course that sxs would improve.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Fall
Clinical narrative: Patient's wife stated on 3/12 patient became extremely confused, weak and fell 3 times. She stated that they were having difficulty getting him up and her daughter called EMS. Patient was taken to hospital and admitted.  Patient is still in hospital, she stated he is more lucid. Patient has history of  Parkinson's
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Increased bronchial secretion, Influenza, Memory impairment
Clinical narrative: Narrative: ON 3/9/21--RECEIVED VACCINE DOSE#1 OF THE MODERNA,APPROX. 0915AM PT STATED HE WENT STRAIGHTHOME--THAT EVENINGPATIENT STATED HAD COLD CHILLS--PT STATED HE THOUGHT IT WAS THE BEGINNING OF THE FLU, BODY WAS HOT. ON 3/10/21-- IN THE AM FEELING SLLUGGISH/WEAK/NO ENERGY, WAS BABYSITTING GRANDSON, IN THE AFTERNOON WENT TO LAY DOWN. (PATIENT DOES NOT REMEMBER THE REST OF THE EVENTS--REPORTED TO HIM LATER BY SPOUSE OF WHAT HAPPENED) PT FOUND GURGLING BY SPOUSE, WIFE CALLED SON-IN-LAW, HE CAME IN BUT AT THE TIME PATIENT HAD STOPPED BREATHING, HE STARTED CPR ON THE PATIENT, AND SOMEONE CALLED 911. PATIENT WOKE UP IN THE AMBULANCE.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory arrest, Resuscitation, Skin warm, Sluggishness
Clinical narrative: Narrative: ON 3/9/21--RECEIVED VACCINE DOSE#1 OF THE MODERNA,APPROX. 0915AM PT STATED HE WENT STRAIGHTHOME--THAT EVENINGPATIENT STATED HAD COLD CHILLS--PT STATED HE THOUGHT IT WAS THE BEGINNING OF THE FLU, BODY WAS HOT. ON 3/10/21-- IN THE AM FEELING SLLUGGISH/WEAK/NO ENERGY, WAS BABYSITTING GRANDSON, IN THE AFTERNOON WENT TO LAY DOWN. (PATIENT DOES NOT REMEMBER THE REST OF THE EVENTS--REPORTED TO HIM LATER BY SPOUSE OF WHAT HAPPENED) PT FOUND GURGLING BY SPOUSE, WIFE CALLED SON-IN-LAW, HE CAME IN BUT AT THE TIME PATIENT HAD STOPPED BREATHING, HE STARTED CPR ON THE PATIENT, AND SOMEONE CALLED 911. PATIENT WOKE UP IN THE AMBULANCE.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time shortened, Anticoagulant therapy, Basophil percentage, Blood calcium normal, Blood glucose increased
Clinical narrative: fatigue, body aches, chills, poor appetite Narrative: Patient is a 65 year-old-male who received the Moderna COVID-19 vaccine on 2/12/21. On 2/23/21, patient contacted his primary care nurse to inform he was having side effects from the vaccine, including headache, fever, chills, fatigue, body aches, rash on top of his feet that extends to his knees, bumps on his chest, bleeding from nose, mouth, and gums, and hyperglycemia. Patient reported took aspirin and Airborne for the symptoms. His primary care provider ordered bloodwork to be done the next day. On 2/24/21, patient had the following labs done: BMP (WNL except for glucose which was 363 mg/dL), CBC with diff (notable for very low platelets of 1 K/mm3), and PT/INR/PTT (all WNL). PCP examined patient and noted no obvious rash on chest, skin fair but not pale, no significant bruising or acute bleeding but petechial rash from the knees down. Patient had been sent home to rest while awaiting lab results. Once lab results returned, patient was contacted and instructed to go to the local ED due to his critically low platelets. Patient went to the local ED, bloodwork showed platelets of 4000 at that time. He was tested for COVID-19 on presentation and was found to be COVID-positive. Patient was diagnosed with idiopathic thrombocytopenia purpura. He was given a total of 4 platelet transfusions as well as IVIG for 2 days and prednisone for 4 days. Platelets reached 78,000 before patient was discharged on 2/26/21. At the time of this reaction, patient's active medications included: metformin, testosterone cypionate inj, allopurinol, atorvastatin, carvedilol, dulaglutide, empagliflozin, lisinopril, aspirin, calcium/vitamin D, multivitamin. He also received the TDaP vaccine 1/21/21 (22 days prior to the COVID-19 vaccine). Post-discharge follow up with primary care provider on 3/5/21 revealed patient feeling better, no bruising, bleeding, fever, or chills since discharge. Patient finished the course of oral prednisone started in the hospital. Glucose remains elevated. PMD to recheck CBC for platelets once patient is done with his mandatory quarantine for positive COVID-19 test results.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood immunoglobulin G, Blood potassium normal, Blood smear test, Blood sodium normal, Blood test abnormal
Clinical narrative: fatigue, body aches, chills, poor appetite Narrative: Patient is a 65 year-old-male who received the Moderna COVID-19 vaccine on 2/12/21. On 2/23/21, patient contacted his primary care nurse to inform he was having side effects from the vaccine, including headache, fever, chills, fatigue, body aches, rash on top of his feet that extends to his knees, bumps on his chest, bleeding from nose, mouth, and gums, and hyperglycemia. Patient reported took aspirin and Airborne for the symptoms. His primary care provider ordered bloodwork to be done the next day. On 2/24/21, patient had the following labs done: BMP (WNL except for glucose which was 363 mg/dL), CBC with diff (notable for very low platelets of 1 K/mm3), and PT/INR/PTT (all WNL). PCP examined patient and noted no obvious rash on chest, skin fair but not pale, no significant bruising or acute bleeding but petechial rash from the knees down. Patient had been sent home to rest while awaiting lab results. Once lab results returned, patient was contacted and instructed to go to the local ED due to his critically low platelets. Patient went to the local ED, bloodwork showed platelets of 4000 at that time. He was tested for COVID-19 on presentation and was found to be COVID-positive. Patient was diagnosed with idiopathic thrombocytopenia purpura. He was given a total of 4 platelet transfusions as well as IVIG for 2 days and prednisone for 4 days. Platelets reached 78,000 before patient was discharged on 2/26/21. At the time of this reaction, patient's active medications included: metformin, testosterone cypionate inj, allopurinol, atorvastatin, carvedilol, dulaglutide, empagliflozin, lisinopril, aspirin, calcium/vitamin D, multivitamin. He also received the TDaP vaccine 1/21/21 (22 days prior to the COVID-19 vaccine). Post-discharge follow up with primary care provider on 3/5/21 revealed patient feeling better, no bruising, bleeding, fever, or chills since discharge. Patient finished the course of oral prednisone started in the hospital. Glucose remains elevated. PMD to recheck CBC for platelets once patient is done with his mandatory quarantine for positive COVID-19 test results.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urea increased, COVID-19, Chills, Differential white blood cell count abnormal, Eosinophil percentage increased
Clinical narrative: fatigue, body aches, chills, poor appetite Narrative: Patient is a 65 year-old-male who received the Moderna COVID-19 vaccine on 2/12/21. On 2/23/21, patient contacted his primary care nurse to inform he was having side effects from the vaccine, including headache, fever, chills, fatigue, body aches, rash on top of his feet that extends to his knees, bumps on his chest, bleeding from nose, mouth, and gums, and hyperglycemia. Patient reported took aspirin and Airborne for the symptoms. His primary care provider ordered bloodwork to be done the next day. On 2/24/21, patient had the following labs done: BMP (WNL except for glucose which was 363 mg/dL), CBC with diff (notable for very low platelets of 1 K/mm3), and PT/INR/PTT (all WNL). PCP examined patient and noted no obvious rash on chest, skin fair but not pale, no significant bruising or acute bleeding but petechial rash from the knees down. Patient had been sent home to rest while awaiting lab results. Once lab results returned, patient was contacted and instructed to go to the local ED due to his critically low platelets. Patient went to the local ED, bloodwork showed platelets of 4000 at that time. He was tested for COVID-19 on presentation and was found to be COVID-positive. Patient was diagnosed with idiopathic thrombocytopenia purpura. He was given a total of 4 platelet transfusions as well as IVIG for 2 days and prednisone for 4 days. Platelets reached 78,000 before patient was discharged on 2/26/21. At the time of this reaction, patient's active medications included: metformin, testosterone cypionate inj, allopurinol, atorvastatin, carvedilol, dulaglutide, empagliflozin, lisinopril, aspirin, calcium/vitamin D, multivitamin. He also received the TDaP vaccine 1/21/21 (22 days prior to the COVID-19 vaccine). Post-discharge follow up with primary care provider on 3/5/21 revealed patient feeling better, no bruising, bleeding, fever, or chills since discharge. Patient finished the course of oral prednisone started in the hospital. Glucose remains elevated. PMD to recheck CBC for platelets once patient is done with his mandatory quarantine for positive COVID-19 test results.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis, Fatigue, Full blood count abnormal, Gingival bleeding, Glomerular filtration rate normal
Clinical narrative: fatigue, body aches, chills, poor appetite Narrative: Patient is a 65 year-old-male who received the Moderna COVID-19 vaccine on 2/12/21. On 2/23/21, patient contacted his primary care nurse to inform he was having side effects from the vaccine, including headache, fever, chills, fatigue, body aches, rash on top of his feet that extends to his knees, bumps on his chest, bleeding from nose, mouth, and gums, and hyperglycemia. Patient reported took aspirin and Airborne for the symptoms. His primary care provider ordered bloodwork to be done the next day. On 2/24/21, patient had the following labs done: BMP (WNL except for glucose which was 363 mg/dL), CBC with diff (notable for very low platelets of 1 K/mm3), and PT/INR/PTT (all WNL). PCP examined patient and noted no obvious rash on chest, skin fair but not pale, no significant bruising or acute bleeding but petechial rash from the knees down. Patient had been sent home to rest while awaiting lab results. Once lab results returned, patient was contacted and instructed to go to the local ED due to his critically low platelets. Patient went to the local ED, bloodwork showed platelets of 4000 at that time. He was tested for COVID-19 on presentation and was found to be COVID-positive. Patient was diagnosed with idiopathic thrombocytopenia purpura. He was given a total of 4 platelet transfusions as well as IVIG for 2 days and prednisone for 4 days. Platelets reached 78,000 before patient was discharged on 2/26/21. At the time of this reaction, patient's active medications included: metformin, testosterone cypionate inj, allopurinol, atorvastatin, carvedilol, dulaglutide, empagliflozin, lisinopril, aspirin, calcium/vitamin D, multivitamin. He also received the TDaP vaccine 1/21/21 (22 days prior to the COVID-19 vaccine). Post-discharge follow up with primary care provider on 3/5/21 revealed patient feeling better, no bruising, bleeding, fever, or chills since discharge. Patient finished the course of oral prednisone started in the hospital. Glucose remains elevated. PMD to recheck CBC for platelets once patient is done with his mandatory quarantine for positive COVID-19 test results.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Haematocrit normal, Haemoglobin normal, Headache, Hyperglycaemia, Immune thrombocytopenia
Clinical narrative: fatigue, body aches, chills, poor appetite Narrative: Patient is a 65 year-old-male who received the Moderna COVID-19 vaccine on 2/12/21. On 2/23/21, patient contacted his primary care nurse to inform he was having side effects from the vaccine, including headache, fever, chills, fatigue, body aches, rash on top of his feet that extends to his knees, bumps on his chest, bleeding from nose, mouth, and gums, and hyperglycemia. Patient reported took aspirin and Airborne for the symptoms. His primary care provider ordered bloodwork to be done the next day. On 2/24/21, patient had the following labs done: BMP (WNL except for glucose which was 363 mg/dL), CBC with diff (notable for very low platelets of 1 K/mm3), and PT/INR/PTT (all WNL). PCP examined patient and noted no obvious rash on chest, skin fair but not pale, no significant bruising or acute bleeding but petechial rash from the knees down. Patient had been sent home to rest while awaiting lab results. Once lab results returned, patient was contacted and instructed to go to the local ED due to his critically low platelets. Patient went to the local ED, bloodwork showed platelets of 4000 at that time. He was tested for COVID-19 on presentation and was found to be COVID-positive. Patient was diagnosed with idiopathic thrombocytopenia purpura. He was given a total of 4 platelet transfusions as well as IVIG for 2 days and prednisone for 4 days. Platelets reached 78,000 before patient was discharged on 2/26/21. At the time of this reaction, patient's active medications included: metformin, testosterone cypionate inj, allopurinol, atorvastatin, carvedilol, dulaglutide, empagliflozin, lisinopril, aspirin, calcium/vitamin D, multivitamin. He also received the TDaP vaccine 1/21/21 (22 days prior to the COVID-19 vaccine). Post-discharge follow up with primary care provider on 3/5/21 revealed patient feeling better, no bruising, bleeding, fever, or chills since discharge. Patient finished the course of oral prednisone started in the hospital. Glucose remains elevated. PMD to recheck CBC for platelets once patient is done with his mandatory quarantine for positive COVID-19 test results.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Immunoglobulin therapy, International normalised ratio normal, Lymphocyte percentage, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal
Clinical narrative: fatigue, body aches, chills, poor appetite Narrative: Patient is a 65 year-old-male who received the Moderna COVID-19 vaccine on 2/12/21. On 2/23/21, patient contacted his primary care nurse to inform he was having side effects from the vaccine, including headache, fever, chills, fatigue, body aches, rash on top of his feet that extends to his knees, bumps on his chest, bleeding from nose, mouth, and gums, and hyperglycemia. Patient reported took aspirin and Airborne for the symptoms. His primary care provider ordered bloodwork to be done the next day. On 2/24/21, patient had the following labs done: BMP (WNL except for glucose which was 363 mg/dL), CBC with diff (notable for very low platelets of 1 K/mm3), and PT/INR/PTT (all WNL). PCP examined patient and noted no obvious rash on chest, skin fair but not pale, no significant bruising or acute bleeding but petechial rash from the knees down. Patient had been sent home to rest while awaiting lab results. Once lab results returned, patient was contacted and instructed to go to the local ED due to his critically low platelets. Patient went to the local ED, bloodwork showed platelets of 4000 at that time. He was tested for COVID-19 on presentation and was found to be COVID-positive. Patient was diagnosed with idiopathic thrombocytopenia purpura. He was given a total of 4 platelet transfusions as well as IVIG for 2 days and prednisone for 4 days. Platelets reached 78,000 before patient was discharged on 2/26/21. At the time of this reaction, patient's active medications included: metformin, testosterone cypionate inj, allopurinol, atorvastatin, carvedilol, dulaglutide, empagliflozin, lisinopril, aspirin, calcium/vitamin D, multivitamin. He also received the TDaP vaccine 1/21/21 (22 days prior to the COVID-19 vaccine). Post-discharge follow up with primary care provider on 3/5/21 revealed patient feeling better, no bruising, bleeding, fever, or chills since discharge. Patient finished the course of oral prednisone started in the hospital. Glucose remains elevated. PMD to recheck CBC for platelets once patient is done with his mandatory quarantine for positive COVID-19 test results.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell volume normal, Mean platelet volume, Metabolic function test, Metabolic function test abnormal, Monocyte percentage increased
Clinical narrative: fatigue, body aches, chills, poor appetite Narrative: Patient is a 65 year-old-male who received the Moderna COVID-19 vaccine on 2/12/21. On 2/23/21, patient contacted his primary care nurse to inform he was having side effects from the vaccine, including headache, fever, chills, fatigue, body aches, rash on top of his feet that extends to his knees, bumps on his chest, bleeding from nose, mouth, and gums, and hyperglycemia. Patient reported took aspirin and Airborne for the symptoms. His primary care provider ordered bloodwork to be done the next day. On 2/24/21, patient had the following labs done: BMP (WNL except for glucose which was 363 mg/dL), CBC with diff (notable for very low platelets of 1 K/mm3), and PT/INR/PTT (all WNL). PCP examined patient and noted no obvious rash on chest, skin fair but not pale, no significant bruising or acute bleeding but petechial rash from the knees down. Patient had been sent home to rest while awaiting lab results. Once lab results returned, patient was contacted and instructed to go to the local ED due to his critically low platelets. Patient went to the local ED, bloodwork showed platelets of 4000 at that time. He was tested for COVID-19 on presentation and was found to be COVID-positive. Patient was diagnosed with idiopathic thrombocytopenia purpura. He was given a total of 4 platelet transfusions as well as IVIG for 2 days and prednisone for 4 days. Platelets reached 78,000 before patient was discharged on 2/26/21. At the time of this reaction, patient's active medications included: metformin, testosterone cypionate inj, allopurinol, atorvastatin, carvedilol, dulaglutide, empagliflozin, lisinopril, aspirin, calcium/vitamin D, multivitamin. He also received the TDaP vaccine 1/21/21 (22 days prior to the COVID-19 vaccine). Post-discharge follow up with primary care provider on 3/5/21 revealed patient feeling better, no bruising, bleeding, fever, or chills since discharge. Patient finished the course of oral prednisone started in the hospital. Glucose remains elevated. PMD to recheck CBC for platelets once patient is done with his mandatory quarantine for positive COVID-19 test results.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Mouth haemorrhage, Neutrophil count, Neutrophil percentage decreased, Pain, Petechiae
Clinical narrative: fatigue, body aches, chills, poor appetite Narrative: Patient is a 65 year-old-male who received the Moderna COVID-19 vaccine on 2/12/21. On 2/23/21, patient contacted his primary care nurse to inform he was having side effects from the vaccine, including headache, fever, chills, fatigue, body aches, rash on top of his feet that extends to his knees, bumps on his chest, bleeding from nose, mouth, and gums, and hyperglycemia. Patient reported took aspirin and Airborne for the symptoms. His primary care provider ordered bloodwork to be done the next day. On 2/24/21, patient had the following labs done: BMP (WNL except for glucose which was 363 mg/dL), CBC with diff (notable for very low platelets of 1 K/mm3), and PT/INR/PTT (all WNL). PCP examined patient and noted no obvious rash on chest, skin fair but not pale, no significant bruising or acute bleeding but petechial rash from the knees down. Patient had been sent home to rest while awaiting lab results. Once lab results returned, patient was contacted and instructed to go to the local ED due to his critically low platelets. Patient went to the local ED, bloodwork showed platelets of 4000 at that time. He was tested for COVID-19 on presentation and was found to be COVID-positive. Patient was diagnosed with idiopathic thrombocytopenia purpura. He was given a total of 4 platelet transfusions as well as IVIG for 2 days and prednisone for 4 days. Platelets reached 78,000 before patient was discharged on 2/26/21. At the time of this reaction, patient's active medications included: metformin, testosterone cypionate inj, allopurinol, atorvastatin, carvedilol, dulaglutide, empagliflozin, lisinopril, aspirin, calcium/vitamin D, multivitamin. He also received the TDaP vaccine 1/21/21 (22 days prior to the COVID-19 vaccine). Post-discharge follow up with primary care provider on 3/5/21 revealed patient feeling better, no bruising, bleeding, fever, or chills since discharge. Patient finished the course of oral prednisone started in the hospital. Glucose remains elevated. PMD to recheck CBC for platelets once patient is done with his mandatory quarantine for positive COVID-19 test results.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Platelet count decreased, Platelet transfusion, Prothrombin time normal, Pyrexia, Rash
Clinical narrative: fatigue, body aches, chills, poor appetite Narrative: Patient is a 65 year-old-male who received the Moderna COVID-19 vaccine on 2/12/21. On 2/23/21, patient contacted his primary care nurse to inform he was having side effects from the vaccine, including headache, fever, chills, fatigue, body aches, rash on top of his feet that extends to his knees, bumps on his chest, bleeding from nose, mouth, and gums, and hyperglycemia. Patient reported took aspirin and Airborne for the symptoms. His primary care provider ordered bloodwork to be done the next day. On 2/24/21, patient had the following labs done: BMP (WNL except for glucose which was 363 mg/dL), CBC with diff (notable for very low platelets of 1 K/mm3), and PT/INR/PTT (all WNL). PCP examined patient and noted no obvious rash on chest, skin fair but not pale, no significant bruising or acute bleeding but petechial rash from the knees down. Patient had been sent home to rest while awaiting lab results. Once lab results returned, patient was contacted and instructed to go to the local ED due to his critically low platelets. Patient went to the local ED, bloodwork showed platelets of 4000 at that time. He was tested for COVID-19 on presentation and was found to be COVID-positive. Patient was diagnosed with idiopathic thrombocytopenia purpura. He was given a total of 4 platelet transfusions as well as IVIG for 2 days and prednisone for 4 days. Platelets reached 78,000 before patient was discharged on 2/26/21. At the time of this reaction, patient's active medications included: metformin, testosterone cypionate inj, allopurinol, atorvastatin, carvedilol, dulaglutide, empagliflozin, lisinopril, aspirin, calcium/vitamin D, multivitamin. He also received the TDaP vaccine 1/21/21 (22 days prior to the COVID-19 vaccine). Post-discharge follow up with primary care provider on 3/5/21 revealed patient feeling better, no bruising, bleeding, fever, or chills since discharge. Patient finished the course of oral prednisone started in the hospital. Glucose remains elevated. PMD to recheck CBC for platelets once patient is done with his mandatory quarantine for positive COVID-19 test results.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell count normal, Red cell distribution width normal, SARS-CoV-2 test positive, White blood cell count normal
Clinical narrative: fatigue, body aches, chills, poor appetite Narrative: Patient is a 65 year-old-male who received the Moderna COVID-19 vaccine on 2/12/21. On 2/23/21, patient contacted his primary care nurse to inform he was having side effects from the vaccine, including headache, fever, chills, fatigue, body aches, rash on top of his feet that extends to his knees, bumps on his chest, bleeding from nose, mouth, and gums, and hyperglycemia. Patient reported took aspirin and Airborne for the symptoms. His primary care provider ordered bloodwork to be done the next day. On 2/24/21, patient had the following labs done: BMP (WNL except for glucose which was 363 mg/dL), CBC with diff (notable for very low platelets of 1 K/mm3), and PT/INR/PTT (all WNL). PCP examined patient and noted no obvious rash on chest, skin fair but not pale, no significant bruising or acute bleeding but petechial rash from the knees down. Patient had been sent home to rest while awaiting lab results. Once lab results returned, patient was contacted and instructed to go to the local ED due to his critically low platelets. Patient went to the local ED, bloodwork showed platelets of 4000 at that time. He was tested for COVID-19 on presentation and was found to be COVID-positive. Patient was diagnosed with idiopathic thrombocytopenia purpura. He was given a total of 4 platelet transfusions as well as IVIG for 2 days and prednisone for 4 days. Platelets reached 78,000 before patient was discharged on 2/26/21. At the time of this reaction, patient's active medications included: metformin, testosterone cypionate inj, allopurinol, atorvastatin, carvedilol, dulaglutide, empagliflozin, lisinopril, aspirin, calcium/vitamin D, multivitamin. He also received the TDaP vaccine 1/21/21 (22 days prior to the COVID-19 vaccine). Post-discharge follow up with primary care provider on 3/5/21 revealed patient feeling better, no bruising, bleeding, fever, or chills since discharge. Patient finished the course of oral prednisone started in the hospital. Glucose remains elevated. PMD to recheck CBC for platelets once patient is done with his mandatory quarantine for positive COVID-19 test results.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Injection site pain, Injection site erythema Narrative:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, stomach pain, fatigue Narrative:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: site pain
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling cold, Headache
Clinical narrative: Headache chills Narrative:
Age: 1.92
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain  Narrative:   Other Relevant History:
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pyrexia
Clinical narrative: Fever Insomnia Narrative:  Other Relevant History:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, fatigue Narrative:  diagnosed with covid in September 2020
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Myalgia
Clinical narrative: Myalgia & Diarrhea  Narrative:  Per supervisor report: "[3/12] Muscle Aches and 2 loose stools"   Other Relevant History:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Injection site pain Narrative:
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Injection site pain, Mobility decreased
Clinical narrative: Localized bruising, pain, first at injection site, then inferior to the elbow. Limited range of motion. Bruising/pain resolved in about 10 days.   Narrative:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: tingling in right hand; 2nd dose administered in right  deltoid  Narrative:
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Headache, Injection site pain, Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, fatigue, night sweats, throbbing pain at the injection site. Narrative:
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Night sweats, Pyrexia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, fatigue, night sweats, throbbing pain at the injection site. Narrative:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, NauseaVomiting,  chills Narrative:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache, Myalgia, Fever, NauseaVomiting,  chills Narrative:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pain in extremity, Vomiting
Clinical narrative: NauseaVomiting extremely sore arm, fatigue, chills
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Injection site swelling
Clinical narrative: Headache injection pain, injection site swelling Narrative:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Malaise
Clinical narrative: Headache chills, malaise Narrative:
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Malaise, Myalgia, Nausea, Pyrexia
Clinical narrative: Myalgia, Fever, Diarrhea, NauseaVomiting, malaise Narrative:
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Myalgia, Fever, Diarrhea, NauseaVomiting, malaise Narrative:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia,  NauseaVomiting, Pain/Swelling/Itching @ injection site, Swollen lymph nodes, Light sensitivity Narrative:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Nausea, Photophobia, Vomiting
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia,  NauseaVomiting, Pain/Swelling/Itching @ injection site, Swollen lymph nodes, Light sensitivity Narrative:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash, Rash papular, Sensitive skin, Tenderness
Clinical narrative: delayed cutaneous hypersensitivity reaction.  Rash appeared 11 day post vaccination. Duration approximately 1 week. Covered entire deltoid region. Raised rash and a little tender.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: delayed cutaneous hypersensitivity reaction   Narrative: Onset 8 days post 1st vaccination; duration  lasted approximately 2 days. size about a silver dollar.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Ienction site pain
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Headache, Injection site pain, Myalgia
Clinical narrative: Dizziness, Headache, Myalgia, Arthralgia & NauseaVomiting Narrative:  dose 1-day 2-3-soreness inj site; day 2-3 nausea; aches; dizziness; ha  Other Relevant History:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Vomiting
Clinical narrative: Dizziness, Headache, Myalgia, Arthralgia & NauseaVomiting Narrative:  dose 1-day 2-3-soreness inj site; day 2-3 nausea; aches; dizziness; ha  Other Relevant History:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:   Other Relevant History:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Myalgia, Pain
Clinical narrative: Myalgia, Diarrhea,  Localized pain; fatigue Narrative:  Other Relevant History:
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:   Other Relevant History:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: injection site pain
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Cough, Injection site pain, Myalgia, Wheezing
Clinical narrative: Myalgia, CoughWheeze,  pain at injection site  Narrative:  Per supervisor report: "[3/12] right arm pain, neck pain, cough, low grade temp."  Other Relevant History:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: minor swelling of fingers both hands  Narrative:  swelling occurred within first 5 minutes of observation. Clinical Assessment and vitals normal. Extended observation to 60 minutes and gave 50mg benadryl
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Bursa disorder, Chills, Condition aggravated, Dizziness
Clinical narrative: Dizziness, Arthralgia & Palpitations The problems began with frequent PVCs which were recorded with the patient's loop recorder (has for paroxysmal atrial fibrillation and has occasional PVCs) but these worsened then on 2/14/2021 developed 20 second run of slow VT at the rate of 160 bpm. Palpitations subsided and then February 18 began having arthralgias of bilateral hips and knees. This eased and then on February 20 had sudden severe pains in the right knee which continued to progress until both bursae were bulging and patient could bare walk with toe touch only the right due to the pain. This persisted until March 8 when the patient developed fever of 101 with chills. Went to ER on March 9 where noted to have increased WBCs with Neutrophil shift. Knee improved after IV Tylenol and Rocephin - still tightened quadricep tendon with occasional pain.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gait disturbance, Neutrophil count abnormal, Pain, Palpitations, Pyrexia
Clinical narrative: Dizziness, Arthralgia & Palpitations The problems began with frequent PVCs which were recorded with the patient's loop recorder (has for paroxysmal atrial fibrillation and has occasional PVCs) but these worsened then on 2/14/2021 developed 20 second run of slow VT at the rate of 160 bpm. Palpitations subsided and then February 18 began having arthralgias of bilateral hips and knees. This eased and then on February 20 had sudden severe pains in the right knee which continued to progress until both bursae were bulging and patient could bare walk with toe touch only the right due to the pain. This persisted until March 8 when the patient developed fever of 101 with chills. Went to ER on March 9 where noted to have increased WBCs with Neutrophil shift. Knee improved after IV Tylenol and Rocephin - still tightened quadricep tendon with occasional pain.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tendon pain, Tendonitis, Ventricular extrasystoles, Ventricular tachycardia, White blood cell count increased
Clinical narrative: Dizziness, Arthralgia & Palpitations The problems began with frequent PVCs which were recorded with the patient's loop recorder (has for paroxysmal atrial fibrillation and has occasional PVCs) but these worsened then on 2/14/2021 developed 20 second run of slow VT at the rate of 160 bpm. Palpitations subsided and then February 18 began having arthralgias of bilateral hips and knees. This eased and then on February 20 had sudden severe pains in the right knee which continued to progress until both bursae were bulging and patient could bare walk with toe touch only the right due to the pain. This persisted until March 8 when the patient developed fever of 101 with chills. Went to ER on March 9 where noted to have increased WBCs with Neutrophil shift. Knee improved after IV Tylenol and Rocephin - still tightened quadricep tendon with occasional pain.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain
Clinical narrative: Headache Injection site pain, fatigue Narrative:  Other Relevant History:
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Myalgia
Clinical narrative: Dizziness, Myalgia, Lightheaded and fatigue Narrative:  Other Relevant History:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain Narrative:  Other Relevant History:
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain, Vomiting
Clinical narrative: Headache, NauseaVomiting, Localized pain; fatigue Narrative:
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Deep vein thrombosis, Haemorrhagic transformation stroke, Ischaemic stroke
Clinical narrative: Deceased Narrative: Patient was a 82 yo male with multiple co-morbidities consisting of AF (on warfarin), prio PE, HFrEF, CAD, HTN, mixed CSA/OSA, hypothyroidism, COPD and GERD. Patient was admitted to facility on 7/12/20 after he was found down in his home for 3 days, dx with right MCA ischemic stroke with hemorrhagic conversion. Etiology of CVA was presumed to be secondary to AF/warfarin failure. No treatment with tPA or thrombectomy was initiated as he was outside the window for intervention. Patient was also found to have bilateral DVTs. Patient was then admitted to facility 08/14/20 for end of life care.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Myalgia, Pain, Rhinorrhoea
Clinical narrative: FATIGUE  MILD COVID SYMPTOMS BUT EXCESSIVE  FATIGUE AND BODY ACHES LASTED 1 WEEK.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia, Fever,  NauseaVomiting,  Pain/Redness/Swelling/Itching/Rash @ injection site,  Swollen lymph nodes
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Injection site swelling, Lymphadenopathy, Myalgia, Nausea
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia, Fever,  NauseaVomiting,  Pain/Redness/Swelling/Itching/Rash @ injection site,  Swollen lymph nodes
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia, Fever,  NauseaVomiting,  Pain/Redness/Swelling/Itching/Rash @ injection site,  Swollen lymph nodes
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Sensitive skin, Swelling
Clinical narrative: Swollen armpit  thats sensitive & painful  noticed swelling starting 3/14/2021 recommended following up w/MD
Age: 72.0
Sex: F
Vaccine: FLUA4
Symptoms: Arthralgia, Hypoaesthesia, Pain, Pain in extremity
Clinical narrative: patient's upper arm & shoulder sore starting upon getting vaccine. Numbing pain. Discomfort when moving arm. Full range of motion
Age: 8.0
Sex: F
Vaccine: FLUX
Symptoms: Hypoaesthesia, Joint range of motion decreased
Clinical narrative: Flu vaccine 11-13-20 in Left Arm. Mom reports on 03-12-2021 that child c/o numbness of arm limited rom starting mid January 2021. Symptoms improving now. Full rom returned. numb spot smaller
Age: 75.0
Sex: M
Vaccine: UNK
Symptoms: Erythema multiforme
Clinical narrative: erythema multiforme started few days after 2/19/21 seen in clinic 3/5 & 3/12